001     137562
005     20240229112519.0
024 7 _ |a 10.1016/j.jclinepi.2018.08.021
|2 doi
024 7 _ |a pmid:30196128
|2 pmid
024 7 _ |a 0895-4356
|2 ISSN
024 7 _ |a 1878-5921
|2 ISSN
024 7 _ |a altmetric:47901332
|2 altmetric
037 _ _ |a DKFZ-2018-01442
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Weigl, Korbinian
|0 P:(DE-He78)f4e98340e600f7411886c21c7b778d36
|b 0
|e First author
|u dkfz
245 _ _ |a A web-based survey among adults aged 40-54 years was time-effective and yielded stable response patterns.
260 _ _ |a Amsterdam [u.a.]
|c 2019
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1680784620_21948
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a We want to present information about response patterns obtained by web-based survey in a large-scale epidemiological study.Within the RAPS (Risk Adapted Prevention Strategies for colorectal cancer) study, we invited 160,000 randomly selected persons aged 40-54 years in three large German cities from 2015 to 2016 to complete a web-based questionnaire on colorectal cancer risk factors and screening (97 items, average time for completion 15 minutes). Invitation letters and up to two reminder letters were sent to each individual.A total of 21.4% of women and 18.0% of men completed the questionnaire. Overall cumulative response rates were 7.5%, 14.3% and 19.6% after the initial invitation letter, and the first and second reminder, respectively, with prevalences of and associations of key epidemiological parameters (such as family history of cancer, previous colonoscopy etc.) being remarkably stable over across waves of responses. For example, the sex and age distribution of the sample did not change with additional answers gained from additional letters.Web-based questionnaires are feasible, cost- and time-effective in the setting of large-scale epidemiological studies. Although response patterns were remarkably stable over several rounds of reminders with substantially increasing cumulative response rates, future research should address possibilities to further enhance response rates.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Tikk, Kaja
|0 P:(DE-He78)eabbefb821cdb73961a5adf967330b62
|b 1
|u dkfz
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 2
|u dkfz
700 1 _ |a De Toni, Enrico N
|b 3
700 1 _ |a Hampe, Jochen
|b 4
700 1 _ |a Kolligs, Frank
|b 5
700 1 _ |a Klug, Stefanie J
|b 6
700 1 _ |a Mansmann, Ulrich
|b 7
700 1 _ |a Nasseh, Daniel
|b 8
700 1 _ |a Radlovic, Jovana
|0 P:(DE-He78)899b5640008ec057830dcc827fa90dbc
|b 9
|u dkfz
700 1 _ |a Schwab, Matthias
|0 P:(DE-He78)0321c153233e619c095d93d9d5546c9d
|b 10
|u dkfz
700 1 _ |a Schweigler, Dirk
|0 P:(DE-He78)19cac162b80393b32f89f3d389c55732
|b 11
|u dkfz
700 1 _ |a Stephan, Anna
|b 12
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 13
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.jclinepi.2018.08.021
|g p. S0895435618304128
|0 PERI:(DE-600)1500490-9
|p 10-18
|t Journal of clinical epidemiology
|v 105
|y 2019
|x 0895-4356
909 C O |p VDB
|o oai:inrepo02.dkfz.de:137562
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)f4e98340e600f7411886c21c7b778d36
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)eabbefb821cdb73961a5adf967330b62
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)899b5640008ec057830dcc827fa90dbc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)0321c153233e619c095d93d9d5546c9d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)19cac162b80393b32f89f3d389c55732
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J CLIN EPIDEMIOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)L801-20160331
|k L801
|l DKTK Tübingen
|x 1
920 1 _ |0 I:(DE-He78)L701-20160331
|k L701
|l DKTK München
|x 2
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 3
920 1 _ |0 I:(DE-He78)G110-20160331
|k G110
|l Präventive Onkologie
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)L801-20160331
980 _ _ |a I:(DE-He78)L701-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a I:(DE-He78)G110-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21